A 29-year-old man was diagnosed with a clinical stage IIIB nonseminomatous germ cell tumor of the testis (NSGCT). He presented with an elevated alpha-fetoprotein level of 4533 and a retroperitoneal mass measuring 22 cm. After frontline chemotherapy comprising bleomycin, etoposide, and cisplatin (BEP) ×4, pathologic examination from a RPLND and left orchiectomy showed less than 5% teratoma with extensive necrosis in the residual lymph node.
embryonic tumor to grow in this manner at this rate.
1,2 For men with relapsed NSGCT, a multimodality approach of chemotherapy combined with resection of all residual disease is the standard of care. Although the overall cure rate is high (>90%), early detection still offers the best potential for successful treatment.
